| Product |
CAS |
Molecular formula |
More |
| 6-O-desmethoxyethyl-6-o-chloroethyl erlotinib hydrochloride |
183320-04-9 |
C21H21Cl2N3O3 |
More |
| 7-O-desmethoxy-7-o-chloroethyl erlotinib hydrochloride |
183320-19-6 |
C21H21Cl2N3O3 |
More |
| 1-Cyclopropyl-7-8-difluoro-6-methoxy-4-oxo-1,4-dihydroquinoline-3-carb |
1329836-33-0 |
C16H15F2NO4 |
More |
| 6-Cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2h-1l3-[1,3]dio |
139693-52-0 |
C22H29FO5 |
More |
| Ethyl n-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-n-pentanoyl |
1111177-30-0 |
C26H33N5O3 |
More |
| S)-2-(((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)amino)-3-methy |
676129-92-3 |
C19H21N5O2 |
More |
| N-desmethyl rosuvastatin-d3 |
371775-74-5 |
C21H23D3FN3O6S |
More |
| Diethyl 2,6-bis((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydrop |
331258-31-2 |
C22H29FO5 |
More |
| Vildagliptin impurity k |
565453-39-6 |
C17H26N2O4 |
More |
| (2R)-1-[2-[(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)amino]acetyl]-2-py |
1036959-27-9 |
C17H25N3O2 |
More |
| 4-Vinyl-piperidine-4-carboxylic acid ethyl ester |
1509910-91-1 |
C10H17NO2 |
More |
| 1,3-Bis[4-chloro-3-(trifluoromethyl)phenyl]urea |
370-50-3 |
C15H8Cl2F6N2O |
More |
| Bms-589154) |
1686149-74-5 |
C22H29FO5 |
More |
| 4-Desmethoxypropoxyl-4-methoxy rabeprazole |
102804-77-3 |
C15H15N3O2S |
More |
| N-desacetyl-n,o-descarbonyl o-acetyl linezolid |
333753-71-2 |
C15H22FN3O3 |
More |
| Desacetyl-n,o-descarbonyl linezolid |
333753-72-3 |
C13H20FN3O2 |
More |
| Linezolid n-oxide |
189038-36-6 |
C16H20FN3O5 |
More |
| 4-(2,3-Dichlorophenyl)-2,6-dimethyl-3-pyridinecarboxylic acid methyl e |
105383-68-4 |
C15H13Cl2NO2 |
More |
| Methyl 2,3-dichloro-3-methyl-5-oxo-1,2,5,6-tetrahydro-[1,1-biphenyl]-2 |
1801167-49-6 |
C22H29FO5 |
More |
| 3,5-Pyridinedicarboxylic acid,4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-d |
138279-32-0 |
C15H13Cl2NO4 |
More |
